Background: Across ethnicities, offspring of hypertensive parents (OH) have higher risk of hypertension than offspring of normotensive parents (ON). Sympathetic hyperactivity and reduced nitric oxide availability have been reported in normotensive OH; but the role of vasodilator cyclooxygenase (COX) products is unclear.
INTRODUCTION
E ssential hypertension is a multifactorial condition with an established familial component that crosses ethnicities, at least amongst those of black African, white European, Japanese and South Asian descent [1] [2] [3] [4] . Given evidence that raised sympathetic nerve activity contributes to the development of hypertension [5] , it is not surprising that black and white American teenage girls and boys who were offspring of hypertensive parents (OH), showed greater pressor responses to mental stress than those with normotensive parents (ON) [6] . Further, in young European men (mean age 27 years), mental stress evoked significant increases in muscle sympathetic nerve activity in OH, but not ON [7] .
There is also evidence, however, that endotheliumdependent dilatation is blunted in young OH. Thus, flow-mediated dilatation (FMD) of the brachial artery, was smaller in young OH, than ON men and women [8] . Further, vasodilator responses evoked in circulation of whole forearm by acetylcholine (ACh) infusion were blunted in normotensive OH men and women, but normalized to those of ON by infusion of L-arginine, the substrate for NO synthesis. By contrast, cyclooxygenase (COX) inhibition had no effect on ACh-induced forearm dilatation in OH, or ON men and women [9] . It was, therefore, argued that vasodilator prostaglandins make no contribution to endothelium-dependent vasodilatation in the forearm of OH or ON, but the NO pathway is defective in young OH [10] . In a subsequent, longitudinal study, L-arginine enhanced ACh-induced forearm vasodilatation in patients with essential hypertension who were less than 30 years old, and at greater than 30 years, COX inhibition enhanced ACh dilator responses. Similar changes occurred in normotensives, but at 45-60 and greater than 60 years old, respectively [11] . Thus, both ageing and hypertension were accompanied by impairment of the NO pathway followed by up-regulation of a vasoconstrictor influence of the COX pathway, but the changes occurred at a younger age during development of hypertension.
Clearly, these studies on whole forearm circulation did not allow assessment of the contributions of vasodilator prostaglandins [9] . However, forearm circulation includes skeletal muscle and cutaneous circulations; vasodilator prostaglandins contribute to endothelium-dependent dilatation in the cutaneous circulation of young healthy individuals and their contribution is lost with aging and cardiovascular disease [11] [12] [13] [14] .
Thus, in the present study, we hypothesized that endothelium-dependent dilatation is impaired in cutaneous circulation of forearm in young adult OH men relative to ON men and that imbalance in the COX pathway contributes to this. We focussed on men because oestrogen increases production of prostacyclin (PGI 2 ), and decreases production of vasoconstrictor prostanoids in hypertension [15, 16] . These effects seemed likely to complicate comparison of findings in young ON and OH women and to justify a separate study on women. As we intended to recruit participants from a student population that is multiethnic, we decided to include white Europeans and South Asians. We tested our hypotheses by recording changes in forearm cutaneous red cell flux (RCF) evoked during reactive hyperaemia and iontophoresis of ACh, before and after COX inhibition.
METHODS
Experiments were performed on young, healthy male volunteers, aged 19-24 (mean age AE SEM: 20.9 AE 0.28 years), who were students of the University of Birmingham. Inclusion criteria were that they should be free from known cardiovascular or respiratory disorders, nonsmokers and that one or both parents should have essential hypertension, or neither parent was known to have hypertension (OH and ON, respectively). The study was approved by the University Research Ethics Committee and performed in accordance with the Helsinki Declaration. Each participant gave informed consent.
Each participant attended the laboratory twice. In brief, on the first visit, anthropometric data were collected, they were familiarized with the equipment and completed a questionnaire on ethnicity, family medical history, diet, smoking, alcohol consumption and level of physical activity. Dietary information included assessment of weekly consumption of vitamin C-containing fruit and vegetable portions as an index of antioxidant vitamin C intake, oily fish portions as an index of omega-3-fatty acids and vitamin D. Physical activity was rated as sedentary or elective exercise rated as low, medium, high scored as time spent/week (see Table 1 ). All were white European, or South Asian and normotensive; resting arterial blood pressure less than 139/89 mmHg.
For the second visit, the participant attended the laboratory in the morning. For 5 days prior to this, they were asked to refrain from any dietary supplements containing vitamin C. Additionally, they were asked not to consume any vasoactive drugs, including nonsteroidal antiinflammatories, or alcohol for 24 h and to avoid caffeine, heavy meals and vigorous exercise for at least 4 h. Each participant acclimatized for 20-30 min and arterial blood pressure (ABP) was recorded by sphygmomanometry. Thereafter, ABP was continuously recorded by photoplethysmography via a finger cuff [17, 18] . A laser Doppler probe inserted into an iontophoresis chamber filled with a 1% solution of ACh in distilled, de-ionized sterile water, was fixed to the left forearm [17, 18] , to continuously monitor forearm skin perfusion, as cutaneous red cell flux (RCF) in perfusion units.
Experimental protocol
Following baseline recordings for 5 min, reactive hyperaemia was recorded following arterial occlusion at 200 mmHg for 3 min, until perfusion returned to baseline again. ACh was then delivered by iontophoresis: seven pulses of 0.1 mA and an eighth pulse of 0.2 mA for 20 s each, separated by 60 s intervals. Recordings of RCF and ABP were made continuously until 5 min following the final iontophoretic pulse [17, 18] .
The participant drank orange squash containing 600 mg aspirin. The iontophoresis chamber and probe were then placed on a different site on the same arm, with a similar baseline as the original site: this was done because skin perfusion remained high for 30-60 min following ACh iontophoresis. The protocol was repeated 30 min after aspirin intake, when COX inhibition is maximal [17, 18] .
Placebo/reproducibility protocol
The protocol was performed on eight ON subjects who drank orange squash containing no aspirin (placebo) to test for reproducibility of reactive hyperaemia and ACh-evoked responses at different sites on forearm skin. 
Data analyses
For reactive hyperaemia, RCF was measured as change from baseline at peak, 30 s, 1 and 2 min after release of occlusion. Responses evoked by ACh were calculated as change from baseline to maximal RCF for each iontophoresis pulse; a compacted mean for each participant was also calculated as the average of these changes [17, 18] . Differences between and within ON and OH groups were assessed by two-way ANOVA and two-way repeated measures ANOVA, respectively. For reactive hyperaemia, Scheffe's post hoc test was used to determine times at which responses differed. Compacted means for ACh responses were compared between and within groups by Student's un-paired and paired t-tests, respectively. Anthropometric and baseline data were compared between OH and ON with one-way ANOVA. Comparable analyses were performed between and within the 12 white Europeans and 12 South Asians and for the subgroups of OH and ON within white Europeans and South Asians. Power calculations based on previous and pilot data indicated that a subgroup size of six was sufficient to detect a 50% reduction in peak reactive hyperaemia and a 30% reduction in mean ACh responses after aspirin intake with 80% power in both the white European and South Asian ONs at P less than 0.05. For the placebo protocol, a coefficient of variation was calculated on data collected on repetition of the stimuli. P less than 0.05 was considered significant throughout.
RESULTS
There were no significant differences between OH and ON groups for anthropometric, cardiovascular or lifestyle characteristics (Table 1) . Baseline RCF values were not significantly different between OH and ON before (13.0 AE 0.7 vs. 13.3 AE 0.7 perfusion units, respectively), or after aspirin intake (14.7 AE 1.1 vs. 13.8 AE 0.7 perfusion units); P greater than 0.05 in each case.
Reactive hyperaemia
Peak reactive hyperaemia was substantially higher in ON than OH, the disparity being maintained until 30 s (Fig. 1a  compared with 1b) . By contrast, after aspirin intake, reactive hyperaemia was greater in OH, than ON (Fig. 1b) . Within ON, reactive hyperaemia was significantly attenuated by aspirin ( Fig. 1a and c) . By contrast, aspirin had no significant effect on peak reactive hyperaemia in OH (Fig. 1b) ; it was attenuated by greater than 50% in two individuals, augmented by greater than 30% in five, and changed by less than 10% in the remainder (Fig. 1d ). : P < 0.05 between ON and OH groups before and after aspirin intake, respectively. OH, offsprings of hypertensive parents; ON, offsprings of normotensive parents.
Acetylcholine-evoked dilatation
Before aspirin intake, cutaneous vasodilator responses evoked by ACh were blunted in OH relative to ON ( Fig. 2a compared with 2b) . By contrast, following aspirin intake, ACh-evoked responses were blunted in ON relative to OH (Fig. 2b) . Within groups, ACh-evoked responses were attenuated after aspirin in ON (see Fig. 2a and c) , the mean response decreasing from 169.1 AE 20.4 to 95.4 AE 13.7 perfusion units (P < 0.01). By contrast, aspirin had no significant effect on ACh-evoked responses in OH ( Fig. 2b and d) ; they were attenuated by at least 30% from control response in three individuals, augmented by 15-40% in four and changed by less than 10% in the remainder.
Comparisons between white Europeans and South Asians
None of the baseline characteristics was significantly different between South Asians and white Europeans except diastolic pressure and mean arterial blood pressure (MABP), which were higher in South Asians (Table 2) . Peak reactive hyperaemia was not significantly different between South Asians and white Europeans before or after aspirin intake ( Fig. 3a and b) . Moreover, aspirin did not cause significant attenuation of peak hyperaemia in white Europeans or South Asians. By contrast, both before and after aspirin intake, vasodilator responses evoked by ACh were blunted in South Asians relative to white Europeans (Fig. 4a  and b ), but any effect of aspirin did not reach statistical significance in either ethnicity (P ¼ 0.12 in white Europeans; P ¼ 0.14 in South Asians).
Considering the effects of aspirin within the ON and OH subgroups of white Europeans and South Asians, reactive hyperaemia was attenuated by aspirin in ONs of both white 
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Europeans and South Asians ( Fig. 3c and d ), but not in OHs of either ethnicity ( Fig. 3e and f) . Similarly, within white Europeans and South Asians, ACh responses were attenuated by aspirin in ON, but not OH (Fig. 4c-f 
DISCUSSION
The present study showed that both reactive hyperaemia and dilatation evoked in cutaneous circulation by the endothelium-dependent dilator ACh were blunted in young OH men relative to ON men. Further, COX inhibition with aspirin attenuated reactive hyperaemia and the AChevoked responses in ON, but not in OH.
Impaired endothelial-dependent dilatation in cutaneous circulation of offspring of hypertensive parents
That forearm cutaneous vasodilatation evoked by iontophoresis of ACh was blunted in young OH men, is consistent with vasodilatation induced in whole forearm by infusion of ACh being blunted in OH men and women aged 23-24 years [9] ; our finding that reactive hyperaemia was blunted is novel. There is a structural limitation on maximal vasodilatation and rarefaction of capillaries in essential hypertension, and it has been suggested these changes begin early in the development of hypertension [19] . However, it is unlikely structural abnormalities explain the present results for in young men (22-33 years) who were ON or OH, but had normal, or high resting ABP, only the hypertensive OH group showed reduced maximal vasodilatation and capillary rarefaction in forearm cutaneous circulation [20] . Thus, blunted endothelium-dependent dilatation in the young OH men is the more probable explanation. That COX inhibition attenuated ACh-evoked cutaneous dilatation of ON, but not OH men contrasts with the lack of effect of COX inhibition on ACh-evoked dilatation in the whole forearm of mixed male/female groups of 8 ON and 10 OH [9] . The simplest explanations for this disparity are that responses evoked by ACh in skeletal muscle overshadowed those in cutaneous circulation and/or inclusion of women confounded the issue [15, 16] . As COX inhibition also attenuated reactive hyperaemia in the cutaneous circulation of young ON, we deduce that vasodilator prostaglandins, probably prostacyclin (PGI 2 ) the commonest endothelial prostaglandin [21] , contribute to both vasodilator responses in cutaneous circulation of young ON, but not OH men.
Our finding that COX inhibition hardly changed peak reactive hyperaemia or ACh-evoked dilatation in 40% of OH, and substantially augmented them in $40% of OH agrees with evidence that prostacyclin or IP receptors that conventionally respond to PGI 2 become dysfunctional during development of hypertension in young spontaneously hypertensive rats and with ageing, whereas the TP receptors that conventionally respond to thromboxane and mediate vasoconstriction, become responsive to PGI 2 [21] . Accordingly, a TP receptor antagonist augmented ACh-evoked dilatation and FMD in patients with coronary artery disease or atherosclerosis [22, 23] . We acknowledge that TP receptor inhibition did not affect reactive hyperaemia in the skin of normotensive men aged 20-30 years [24] , but their OH/ON status was not recorded. In view of the present results, a study on TP receptor inhibition on young OH and ON men would seem justified.
The question arises as to why the cutaneous dilator responses that persisted after COX inhibition were substantially larger in OH, than ON men. COX products can inhibit NO synthesis in cutaneous circulation [25] . Thus, COX inhibition might have allowed NO to make a larger contribution to ACh-evoked dilatation and reactive hyperaemia in OH, than ON men. This is unlikely given NO makes little contribution to either response in cutaneous circulation [13, [26] [27] [28] [29] and given NO availability is attenuated during development of hypertension in young OH men [9, 10] . Alternatively, COX inhibition may have revealed the dilator influence of endothelium-derived hyperpolarizing factor/s (EDHFs), which include a cytochrome P450 epoxygenase (CYP 2C) metabolite [26, 30, 31] . EDHFs provide a dilator reserve early in endothelial dysfunction [21] and CYP 2C metabolites compensated for impaired NO availability in the forearm of newly diagnosed hypertensive patients who were OH [31] . Thus, CYP 2C metabolites may help maintain cutaneous vasodilator responses of young OH men at a stage when the dilator influences of prostaglandins are deficient. This remains to be explored. In previous studies, the effects of COX inhibition on cutaneous circulation of normotensive participants have been highly variable. COX inhibition attenuated ACh-evoked dilatation in six men aged 23 -36 years [11] , in mixed male/female groups of 12, 23 or 11 individuals of 23-30 years [13, 14, 32] and reactive hyperaemia in six men and women aged 27-40 years [12] . By contrast, COX inhibition had no effect on these responses in mixed groups of nine, or six men and women aged 18-30 years [33, 34] , but augmented reactive hyperaemia in 12 men and women aged 19 -25 years [25] . Given the small group sizes, the influences of sex and age on the contributions of COX products [13, [15] [16] [17] [18] and the fact that ON/ OH status was not considered, it seems likely these variable outcomes reflected within group variability. Indeed, the present results indicate that in healthy men in young adulthood (19 -24 years) , of similar life styles and levels of physical activity, ON/OH status is the dominant factor determining the effects of COX inhibition on reactive hyperaemia and ACh-evoked dilatation. The high reproducibility of both responses in ON men who received placebo rather than COX inhibitor is consistent with that proposal.
Effects of ethnicity
We recruited equal numbers of white Europeans and South Asians in the ON and OH groups, knowing the prevalence of cardiovascular disease (CVD) is higher in South Asians and associated with endothelial dysfunction [35] . Accordingly, diastolic pressure was higher in the young South Asian than white European men consistent with increased peripheral resistance in young South Asian men. Further, ACh-evoked dilatator responses though not reactive hyperaemia, were blunted in young South Asian, relative to white European men. Similarly, we recently showed that reactive hyperaemia and vasodilator responses to mental stress were blunted in forearm of young normotensive South Asian men, relative to white European men [36] . Moreover, FMD and the tonic dilator influence of NO on forearm were also blunted in young normotensive South Asian, relative to white European men [37] . Indeed, it seems endotheliumdependent dilatation is impaired even in young South Asian men with no overt CVD.
Nevertheless, a key finding of the present study is that in both young white European and South Asian men, COX inhibition attenuated reactive hyperaemia and ACh-evoked dilatation in cutaneous circulation of ON, just as in the full group of mixed ethnicity. Given the heritable proportion of ABP is 40-60% in white Europeans and South Asians [1, 4] , it may be that the future risk of hypertension is lower in the minority of individual OH in whom COX inhibition attenuates cutaneous dilator responses, but higher in those in whom responses are augmented. Factors such as central obesity, physical inactivity, high life stress and hyperresponsiveness to stressors determine whether individual OH, or ON develop hypertension [1] [2] [3] [4] 38] and the prevalence of central obesity and diabetes is higher among South Asians [35] . Thus, it would not be surprising if the proportion of OH men who actually develop hypertension and CVD were greater amongst South Asians than white Europeans.
Study limitations
Like most studies on ON/OH (see [6] [7] [8] ), we did not verify whether the parents of ON had hypertension. Thus, some may have been undiagnosed, or develop hypertension in the future. However, young OH men whose parents had hypertension in early middle-age are at higher risk of hypertension than those whose parents developed hypertension in late middle-age [39] . It is, therefore, reasonable to assume that the OH men were the highest risk group. It is a limitation that we assessed BMI but not body fat distribution. However, in a recent study, BMI, waist:hip ratio and fasting glucose levels were similar in young South Asian and WE men, but fasting insulin was at the high end of the normal range in South Asians, consistent with their depressed endothelium-dependent dilatation [37] . Thus, we have missed early signs of diabetes in some South Asian men. Importantly, our proposals should be tested in a larger population of young men and women.
Considering our experimental stimuli, release of sensory nerve peptides has been implicated in reactive hyperaemia and vasodilatation evoked by iontophoresis of ACh [26, 33] . We used a shorter period of arterial occlusion (3 vs. 5 min) and delivered ACh with a lower current than in those studies. Moreover, we showed that iontophoresis of vehicle with the same protocol as we used for ACh had minimal effects on cutaneous perfusion, whereas COX inhibition had no effect on responses evoked by iontophoresis of the endothelium-independent dilator sodiumnitroprusside [17, 18] . Thus, whilst we cannot exclude involvement of neuropeptides released directly by ischaemia or current, or by their ability to stimulate synthesis of mediators, such as prostaglandins [26, 33] , it seems reasonable to assume the responses we report mainly reflect direct effects of ischemia and ACh on endotheliumdependent dilatation.
In conclusion, the present study on normotensive men in the 19-24 years age range, indicates that OH men of white European and South Asian ethnicity show blunted reactive hyperaemia and ACh-evoked vasodilatation in cutaneous circulation relative to ON men, attributable to a depressed contribution of vasodilator prostaglandins. These early signs of endothelial dysfunction precede development of frank hypertension, but may contribute causally to its pathogenesis [40] .
